These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 33145457)

  • 1. Cystoid macular edema.
    Rotsos TG; Moschos MM
    Clin Ophthalmol; 2008 Dec; 2(4):919-30. PubMed ID: 19668445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction of cystoid macular edema from the fovea after intravitreal anti-VEGF therapy for birdshot chorioretinopathy.
    Ba-Ali S; Fuchs J; Larsen M
    Retin Cases Brief Rep; 2023 Oct; ():. PubMed ID: 37874763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cystoid macular oedema secondary to pentosan polysulfate maculopathy using anti-VEGF and intravitreal steroid injections.
    De Silva SR; De Silva I; Pal B
    Eur J Ophthalmol; 2021 Dec; ():11206721211066387. PubMed ID: 34866437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystoid Macular Edema Arising 10 Years After Cessation of Pentosan Polysulfate Sodium Successfully Treated With Bevacizumab.
    Szelog JT; Shah NS; Camejo MD
    J Vitreoretin Dis; 2023; 7(1):83-86. PubMed ID: 37008392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection.
    Ueta Y; Kamada R; Watanabe Y; Tanaka N
    Case Rep Ophthalmol; 2023; 14(1):620-625. PubMed ID: 38023610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal anti-vascular endothelial growth factor therapy in the treatment of vision loss associated with hematologic malignancy.
    Toohey TP; Shortt J; John N; Al-Qureshi S; Wickremasinghe SS
    Am J Ophthalmol Case Rep; 2024 Dec; 36():102095. PubMed ID: 39114297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystoid Macular Edema: A Rare Adverse Reaction to Rituximab.
    Machado AI; Marques M; Vieira M
    Cureus; 2024 Jan; 16(1):e52867. PubMed ID: 38406024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Retinopathy and Benign Lymphoproliferative Orbital Tumor Presenting 47 Years Following Treatment of Hereditary Retinoblastoma.
    Sabbagh MA; Munro MP; Mieler WF
    Retin Cases Brief Rep; 2023 Dec; ():. PubMed ID: 38055910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration.
    Sotani R; Matsumiya W; Kim KW; Miki A; Yasuda E; Maeda Y; Hara R; Kusuhara S; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):671. PubMed ID: 38095690
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis.
    Saba NJ; Walter SD
    Clin Ophthalmol; 2023; 17():2791-2802. PubMed ID: 37753246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies.
    Karasavvidou EM; Tranos P; Panos GD
    Drug Des Devel Ther; 2022; 16():2659-2680. PubMed ID: 35971530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Retinopathy: Detection and Management Strategies.
    Sahoo NK; Ranjan R; Tyagi M; Agrawal H; Reddy S
    Clin Ophthalmol; 2021; 15():3797-3809. PubMed ID: 34526764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab.
    Corradetti G; Corvi F; Juhn A; Sadda SR
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100981. PubMed ID: 33145457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma.
    Villegas NC; Mishra K; Steinle N; Liu W; Beadle B; Mruthyunjaya P
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101581. PubMed ID: 35599950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series.
    Chakraborty D; Sheth JU; Boral S; Sinha TK
    Am J Ophthalmol Case Rep; 2021 Dec; 24():101197. PubMed ID: 34504981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral effect following off label unilateral intravitreal brolucizumab injection in patient with pseudophakic cystoid macular edema.
    Kelkar A; Bolisetty M; Jadhav A
    Eur J Ophthalmol; 2024 Mar; 34(2):NP48-NP51. PubMed ID: 37644807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.